DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Van Cutsem E, Rivera F, Berry S. , et al; First BEAT Investigators.
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
Ann Oncol 2009;
20 (11) 1842-1847
We do not assume any responsibility for the contents of the web pages of other providers.